News Release
You can select the year, month, and category you wish to view.
- All
- Business Development
- Drug Discovery
- General Meeting of Shareholders
- Financial Information
- Other
-
2022.11.16
Notice of Achievement of Target Number of Patients in Early stage Phase II Clinical Trial of PC-SOD
(152KB)
-
2022.10.26
Notice of Lecture by Tohru Mizushima, CEO of the Company, at Niigata University, a National University Corporation
(122KB)
-
2022.09.28
Announcement of the start of Phase III clinical trials for LT-5001
(120KB)
-
2022.09.14
Notice of Invited Lecture by Tohru Mizushima, CEO of Minebea, at CSJ Chemistry Festa
(126KB)
-
2022.08.31
Notice of Joint Research Agreement with National Institutes for Quantum Science and Technology
(147KB)
-
2022.08.10
Notice of Joint Research Agreement with Kanagawa Cancer Center
(122KB)
-
2022.04.25
Notice of a Contract Agreement with a Major Japanese Pharmaceutical Company for DDS Drug Development
(122KB)
-
2022.01.21
Announcement of the Start of Early stage Phase II Clinical Trial of PC-SOD
(145KB)
-
2021.10.21
Notice of Results of Late stage Phase II Clinical Trial of LT-5001
(129KB)
-
2021.07.15
Nikkei Biotech Article Published
(119KB)
